On June 9, Core Scientific rose 5.38% in regular trading, trading at $27.21/share, with trading volume of $128 million. The rebound follows a roughly 10% cumulative pullback over the prior two sessions after the company terminated its $9 billion all-stock acquisition agreement with NVIDIA-backed CoreWeave, which was voted down by shareholders.

The terminated deal had aimed to provide CoreWeave with energy and data center computing resources to support its surging demand. While the acquisition collapse removed a near-term valuation re-rating catalyst, the current stock price remains well below B.Riley's recently raised target price of $33 and the analyst consensus target of $30.12, creating clear valuation recovery potential that is attracting capital inflows on the dip.

Within the Application Software sector, computing-power related stocks rallied broadly, with IREN Ltd up 9.24% and Strategy up 6.54%, providing sector-wide momentum support for Core Scientific's recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)